Officer exercised or converted 533 GILD derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jun 10, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jun 11, 2026
OfficerOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001739515-26-000008
Added to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly IssuerGILEAD SCIENCES, INC. Reporting personDietmar Berger Officer titleChief Medical Officer TableNon-derivative (Table I) Transaction dateJun 10, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Around the same time
CEO sold ~$1.5M of Gilead Sciences
Scheduled in advanceCEO sold ~$394K of Gilead Sciences
Scheduled in advance
Jared Moskowitz boughtDemocrat, Representative, FL district 23D · FL-232 different filers disclosed GILD within 90 days. Disclosed 44 days after the transaction; reported as an official range, not an exact amount.